LumiraDx
LumiraDx Q2 Revenues Fall 53 Percent on Lower COVID-19 Demand
The firm also shipped more than 1,500 new instruments, mostly to US pharmacies to prepare for the upcoming respiratory season.
360Dx Top 30 Continues Rise in July, Increasing 4 Percent
Of the 30 companies in the Top 30, 21 saw their stock prices go up, while eight saw their share prices decline, and one company's stock price remained flat.
Axonlab to Distribute LumiraDx Platform in Switzerland, Germany
Axonlab has the right to promote, market, and sell the LumiraDx platform and tests to hospitals, doctors, clinics, private laboratories, and research institutions.
360Dx Top 30 Rebounds in June, Rising 4 Percent
Of the 30 companies in the Top 30, 20 saw their stock prices go up, while 10 saw their share prices decline.
In Brief This Week: Quest Diagnostics, BD, LumiraDx, Mainz Biomed
News items for the week of June 19, 2023.
Jun 1, 2023
360Dx Top 30 Drops 6 Percent in May
May 1, 2023
360Dx Top 30 Slides 2 Percent in April
Apr 3, 2023
360Dx Top 30 Rebounds 2 Percent in March
Mar 21, 2023
LumiraDx Q4 Revenues Fall 65 Percent
Jul 19, 2022